Financials

Financials — A deleveraging holding company priced on its parts, not its profits

Edelweiss is not one business with one income statement; it is a Mumbai-listed holding company that consolidates seven very different financial businesses — alternative asset management, mutual funds, asset reconstruction (ARC), an NBFC, a housing-finance lender, a general insurer and a life insurer. Read the consolidated statements naively and you will misjudge it in both directions. The headline tells you profit grew 27% to ₹680 crore in FY2026 [1]; the fine print tells you that only ₹547 crore of that belongs to Edelweiss shareholders after minorities, that comprehensive income to owners was actually negative, and that the real investment case lives not in the profit and loss account at all but in the private-market value of the asset-management franchise the company is preparing to list.

This page is built to separate those layers. The core question — does the financial quality, balance-sheet strength and cash generation justify the price — has an unusual answer here: the consolidated earnings are mediocre and low-quality, the balance sheet has been heroically de-risked, and the valuation only makes sense as a sum-of-the-parts bet on monetisation.

Sources: net worth, net debt and consol PAT per FY2026 earnings presentation [2]; owners' PAT and equity per FY2026 audited results [3]; ROE and P/B derived from reported financials and the ₹122.45 close (25 Jun 2026).

What you are actually buying: where the profit is made

The right place to start is not revenue but the earnings distribution across businesses, because the consolidated profit and loss account blends a high-return, asset-light fee engine with two loss-making insurers and a shrinking lending book. In FY2026 the operating businesses earned ₹520 crore pre-minority; asset reconstruction (₹350 crore), alternative asset management (₹265 crore) and the mutual fund (₹85 crore) carried the group, while life and general insurance together lost ₹216 crore and the NBFC plus housing finance contributed just ₹37 crore combined [4].

Source: FY2026 earnings presentation, earnings distribution slide [5].

Three things follow. First, the profit engine is fee-and-spread asset management plus a winding-down ARC, both of which are capital-light or capital-releasing; the alternatives platform (EAAA) grew fee-paying AUM 32% to ₹44,710 crore and the equity mutual-fund AUM rose 25% to ₹78,000 crore [6]. Second, insurance is a structural drag the company is funding toward an FY2027 break-even target. Third, the ₹161 crore of "Corporate" profit in FY2026 — versus a ₹31 crore loss the year before — is not operating profit at all: it is inflated by a one-time deferred-tax-asset recognition booked in the September 2025 quarter from Ind-AS consolidation accounting [7].

The standard year-wise financials

For a financial holding company the conventional "gross margin / operating margin" lines mislead, so the table below shows the lines that actually matter: total income, its quality split (recurring fee income vs. lumpy fair-value gains), the finance cost that dominates the cost base, profit before and after minority interest, EPS, book value attributable to owners, consolidated net debt and the return on owners' equity. Note the FY2024 break: owners' equity fell roughly ₹2,350 crore not from losses but from the demerger of Nuvama Wealth, whose net assets were distributed to shareholders [8].

Sources: FY2026 and FY2025 profit attributable to owners of the Company from audited results [9]; FY2024 and FY2023 total income and owners' PAT from the FY2024 annual report [10]; FY2021 and FY2022 total income and owners' PAT from the FY2022 annual report [11]; net debt per investor presentations [12]; ROE derived from reported financials.

The shape of the business over five years is telling. Total income is essentially flat-to-down across the period — ₹10,849 crore in FY2021 fell to ₹7,305 crore in FY2022 as the legacy wholesale-credit book ran off, then clawed back to ₹10,865 crore by FY2026. This is not a growth company in aggregate; it is a portfolio being re-shaped from a big-balance-sheet lender into an asset-light manager, and the reported income line hides that mix-shift.

Earnings quality: read past the 27% headline

The "27% PAT growth" the company leads with is real arithmetic but low-quality earnings, and four adjustments matter.

1. Minority interest takes a fifth of the profit. Of FY2026's ₹680 crore consolidated profit, ₹134 crore belongs to the minority partners in subsidiaries (notably the life-insurance JV, the ARC and the part-sold alternatives platform); only ₹547 crore is attributable to Edelweiss owners [13]. Management itself frames the growth on the post-minority figure, from ₹399 crore to ₹547 crore [14]. The ₹7.23 EPS in the screens, struck on the pre-minority total, overstates per-share economics by roughly a quarter.

2. Book value is not compounding. Despite positive reported profit, comprehensive income attributable to owners was negative in both FY2025 (−₹417 crore) and FY2026 (−₹186 crore), because other comprehensive income — largely insurance and investment fair-value movements — ran at −₹816 crore and −₹732 crore respectively [15]. That is why owners' equity barely moved (₹4,425 → ₹4,623 crore) even as the company "earned" ₹547 crore.

3. A third of operating revenue is non-cash mark-to-market. Of ₹10,417 crore of revenue from operations in FY2026, ₹3,410 crore — about 33% — was "net gain on fair value changes," and the cash-flow statement adds back ₹3,751 crore of fair-value gains as non-cash [16]. For an ARC and an investment-heavy holding company this is normal, but it makes reported profit lumpy and only loosely tied to cash.

4. Tax and provisioning swings make quarters meaningless in isolation. The September 2025 quarter booked a large deferred-tax credit; the December 2025 quarter reversed it with a ₹565 crore deferred-tax charge against ₹792 crore of pre-tax profit; and the quarterly profit line lurches accordingly. The chart below shows how little signal there is in any single quarter.

Source: quarterly consolidated results as reported to the exchanges; FY2026 quarters reconciled to audited FY2026 results for owners of the Company [17].

The honest read on earnings quality: cash conversion and "free cash flow" are not meaningful lenses here (a lender's operating cash flow swings with loans given and repaid, and insurance float distorts it). The better quality test — recurring fee income versus mark-to-market gains, profit that reaches owners versus minorities, and whether book value grows — all point the same way: the underlying franchise is improving, but the reported number flatters it.

The balance sheet: the genuinely strong part of the story

If earnings quality is the weak chapter, the balance sheet is the strong one. Edelweiss has spent six years dismantling the leverage that nearly killed it after the 2018 IL&FS shock. From a peak of roughly ₹50,000 crore of borrowings, consolidated debt has been cut by about ₹29,000 crore since March 2019 [18]. Consolidated net debt fell from ₹15,340 crore in FY2024 to ₹11,170 crore in FY2025 to ₹10,430 crore in FY2026 [19].

Sources: peak and cumulative reduction per Q1 FY2026 call [20]; FY2024–FY2026 net debt per investor presentations [21].

To appreciate the scale of the shrinkage, compare the loan and borrowing books. In FY2024 the group still carried ₹148,040 crore of loans funded by ₹143,980 crore of debt securities and tens of thousands of crores more in other borrowings [22]. By March 2026 the consolidated loan book was just ₹10,986 crore, against gross debt of about ₹18,500 crore (₹14,672 crore of debt securities, ₹3,142 crore of other borrowings and ₹690 crore of subordinated liabilities), with another ₹10,562 crore of insurance policyholders' liabilities that are matched by policyholder assets [23].

Two cautions keep this from being an unqualified positive. The reported consolidated debt-to-equity ratio actually edged up to 3.11x in FY2026 from 3.02x, and interest-service coverage is a thin 1.36x [24] — leverage has fallen in absolute rupees but, against a shrunken equity base, the ratio is not improving. And ₹6,410 crore of the net debt sits at the corporate/holding-company level, down only modestly from ₹8,048 crore two years earlier [25]; that holdco debt is serviced largely by dividends and monetisations from subsidiaries, which is the structural fragility of any holding company.

Where the balance sheet is unambiguously strong is at the operating-subsidiary level, where each regulated entity is over-capitalised: the NBFC runs 30% capital adequacy, housing finance 29%, the ARC 80%, and the two insurers hold solvency ratios of 157% (general) and 176% (life) [26].

Returns and capital allocation

Return on owners' equity has climbed from ~9% to ~12% over two years, which is respectable but unremarkable for an Indian financial — and it is depressed precisely because two insurance subsidiaries and a low-return credit book sit alongside high-return asset management. The capital-allocation story is therefore less about dividends than about monetisation.

On dividends, the board recommended ₹1.50 per share for FY2026 [27], a ~1.2% yield. Be careful with the consolidated cash-flow line: ₹476 crore of "dividend paid" in FY2026 mostly reflects distributions by subsidiaries to their minority holders, not Edelweiss's own ₹142 crore distribution [28].

The real capital event is the crystallisation of stake value, and FY2026 delivered three concrete third-party transactions:

EAAA (alternatives): Edelweiss sold 4.4% of its alternatives platform for ₹375 crore in March 2026, valuing the whole of EAAA at roughly ₹8,500 crore [29]. It filed its IPO draft prospectus in January 2026 and received SEBI approval in April 2026, with listing pending [30].

Nido (housing finance): Carlyle agreed to invest ₹2,100 crore for a 45% stake, including ₹1,500 crore of primary capital, pending regulatory approvals [31].

Citius (InvIT): EAAA's transport InvIT raised ₹1,105 crore in an April 2026 IPO oversubscribed ~20x, the highest ever for a public InvIT in India [32].

These are not management projections; they are prices set by Carlyle and by IPO investors. They are the load-bearing evidence for the valuation.

Valuation: the sum-of-the-parts is the whole argument

On consolidated metrics, Edelweiss looks expensive. At ₹122.45 (25 June 2026) the equity is worth about ₹11,600 crore, which is ~21x earnings attributable to owners (₹547 crore), ~17x the pre-minority headline, and 2.5x a book value of ₹49 per share — rich for an ~12% ROE.

Source: derived from the ₹122.45 close (25 Jun 2026), ~94.7 crore shares, and FY2026 audited PAT to owners of the Company and book value [33].

But the consolidated lens is the wrong one, and the EAAA mark proves it. The 4.4% placement values the alternatives platform alone at about ₹8,500 crore [34]. Edelweiss owns the overwhelming majority of that — so one of seven businesses is privately marked at roughly 70% of the entire company's market capitalisation. Add the Carlyle price on Nido, the ARC's ₹2,985 crore of equity, the rapidly scaling mutual fund, and two insurers approaching break-even, and the sum-of-parts comfortably exceeds the ₹5,944 crore consolidated net worth — which is why the stock trades at 2.5x that book. The market is not paying 21x for the blended earnings; it is paying for a holding-company discount to a parts value it expects the EAAA IPO to unlock.

Against peers the picture is consistent: Edelweiss earns a return on equity in the same low-teens band as the diversified financials, but with materially lower earnings quality (insurance losses, minority leakage) than the asset-light wealth and broking houses.

Sources: Edelweiss derived from reported financials; peer ROE, margin and revenue growth from each company's reported FY2026 financials (Piramal latest FY2025). JM Financial — the closest structural comparable — is omitted as its computed ratios were unavailable in the corpus. Valuation multiples for peers are not in the corpus and are not shown.

A caution on the peer set: the auto-selected comparables are heterogeneous. 360 ONE and Motilal Oswal are asset-light wealth/broking houses that earn 14–22% ROE without an insurance drag and deservedly trade richer; Aditya Birla Capital, IIFL and Piramal are lending-heavy and structurally lower-return. Edelweiss is genuinely a hybrid, which is exactly why a single consolidated multiple flatters or punishes it depending on which lens you pick — and why the market defaults to a parts-based valuation.

The bottom line

The financials confirm a real, durable de-risking: borrowings down by tens of thousands of crores, over-capitalised regulated subsidiaries, comfortable near-term liquidity, and a profit mix tilting toward capital-light fee businesses. They contradict the bullish headline: the "27% growth" is pre-minority, comprehensive income to owners has been negative for two years, a chunk of FY2026 profit is a one-off deferred-tax credit, and a third of revenue is mark-to-market. On standalone consolidated earnings the stock is not cheap. The entire investment case rests on whether the privately marked value of the asset-management franchise — validated by Carlyle and by the Citius IPO — is crystallised through the pending EAAA listing rather than dribbling away in holdco costs and insurance losses.

The first financial metric to watch is the EAAA listing valuation. Because one business is privately marked at ~70% of Edelweiss's market cap, the price at which EAAA actually lists — and the post-listing reduction in the ₹6,410 crore of corporate net debt it is meant to fund — will do more to the equity than any quarter of consolidated EPS. If EAAA prints near its ~₹8,500 crore private mark and proceeds cut holdco debt, the sum-of-parts is vindicated; if it lists at a discount or slips, the consolidated 21x earnings multiple is what is left.